NMDA drug
Evidence from:
primary |
all sources
Related entities (1)
| Subject | Relation | Object | p-value | Evidence |
|---|---|---|---|---|
| animal models | associated_with | NMDA | — | 1 |
Mentioned in (5)
Papers in which this entity is mentioned.
- Reduction of APOE accounts for neurobehavioral deficits in fetal alcohol spectrum disorders. (2024)
- Alternative Polyadenylation Directs Tissue-Specific miRNA Targeting in Somatic Tissues. (2017)
- Aberrant development of post-movement beta rebound in adolescents and young adults with fetal alcohol spectrum disorders. (2015)
- Prenatal choline supplementation mitigates the adverse effects of prenatal alcohol exposure on development in rats. (2009)
- Association of single nucleotide polymorphisms in a glutamate receptor gene (GRM8) with theta power of event-related oscillations and alcohol dependence. (2009)
Merged raw entities (3)
All extracted name/type variants the normalize job merged into this entity. Use this to spot wrong merges, or aliases that should be split off.
| Raw name | Type | Papers | Mentions |
|---|---|---|---|
| nmda | drug | 56 | 111 |
| n-methyl-d-aspartate | drug | 5 | 6 |
| synthetic agonist nmda | drug | — | — |